Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01005368 · ClinicalTrials.gov registry record
Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia
A clinical trial, sponsored by Alliance for Clinical Trials in Oncology.
- Completed
- Registry status
- 600
- Enrollment target
NCT01005368 is a clinical trial that has completed, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 600 participants.
The verdict
NCT01005368 has completed, sponsored by Alliance for Clinical Trials in Oncology.
- COMPLETED
- Registry status
- 600 participants
- Enrollment target
Study Summary
RATIONALE: Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors identify and learn more about biomarkers related to cancer. PURPOSE: This research study is looking at biomarkers in blood and bone marrow samples from patients with previously untreated chronic lymphocytic leukemia.
Interventions
- GENETIC mutation analysis
- GENETIC polymerase chain reaction
- GENETIC western blotting
- GENETIC fluorescence in situ hybridization
- GENETIC nucleic acid sequencing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2009-10 |
| Est. Completion | 2022-04-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01005368
The ClinicalTrials.gov registry entry for NCT01005368 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alliance for Clinical Trials in Oncology, which has 446 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which mutation analysis is the first listed.
NCT01005368 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01005368 about?
NCT01005368 is a clinical study titled "Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia". RATIONALE: Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors identify and learn more about biomarkers related to cancer. PURPOSE: This research study is looking at biomarkers in blood and bone marrow samples from patients with previously untreated chronic...
What is the current status of trial NCT01005368?
This trial is currently completed. The enrollment target is 600 participants. The study started on 2009-10. Estimated completion is 2022-04-01.
What interventions are being tested in trial NCT01005368?
The interventions under investigation include: mutation analysis (GENETIC), polymerase chain reaction (GENETIC), western blotting (GENETIC), fluorescence in situ hybridization (GENETIC), nucleic acid sequencing (GENETIC).
Who is sponsoring clinical trial NCT01005368?
This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.